This guideline specifies the general quality requirements for non-regulated biomedical research in drug development in order to ensure credibility of biomedical research results. This includes both large and small molecule discovery and non-clinical development that is not covered by GxP. The target audience for this report is the scientific staff at institutions and companies involved in drug development. Compliance with applicable regulatory and safety requirements is not covered by this report.